The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Clinical Relevance of MGMT in the Treatment of Cancer
Abstract
A number of DNA-damaging chemotherapeutic agents attack the O 6 position on guanine, forming the most potent cytotoxic DNA adducts known. The DNA repair enzyme O 6-alkylguanine DNA alkyltransferase (AGT), encoded by the gene MGMT, repairs alkylation at this site and is responsible for protecting both tumor and normal cells from these agents. Cells and tissues vary greatly in AGT expression, not only between tissues but also between individuals. AGT activity correlates inversely with sensitivity to agents that form O 6-alkylguanine DNA adducts, such as carmustine (BCNU), temozolomide, streptozotocin, and dacarbazine. The one exception is those tumors lacking mismatch repair, which renders them resistant to methylating agents. A recent study in patients with gliomas confirmed the correlation between low-level expression of the MGMT gene and response and survival after BCNU. An inhibitor to AGT, O 6-benzylguanine (BG), depletes AGT in human tumors without associated toxicity and is now in phase II clinical trials. Finally, mutations within the active site region of the MGMT gene render the AGT protein resistant to BG inactivation. As a result, mutant MGMT gene transfer into hematopoietic stem cells has been shown to selectively protect the marrow from the combination of an alkylating agent and BG, while at the same time sensitizing tumor cells. MGMT remains a paradigm for development of new agents that modulate known mechanisms of drug resistance in cancer cells and raise the spectra of combinatorial therapies that encompass known drug resistance mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Esteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J. M., Kunkel, T. A., & Boland, C. R. (1994) · PubMed · Cited by 515
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506
Dolan, M. E., Moschel, R. C., & Pegg, A. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5368 · Cited by 460
Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
Hickman, M. J., & Samson, L. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10764 · Cited by 318
DNA damage tolerance, mismatch repair and genome instability
Karran, P., & Bignami, M. (1994) · BioEssays · doi:10.1002/bies.950161110 · Cited by 310
Jaeckle, K. A., Eyre, H. J., Townsend, J. J., Schulman, S., Knudson, H. M., Belanich, M., Yarosh, D. B., Bearman, S. I., Giroux, D. J., & Schold, S. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3310 · Cited by 297
Dumenco, L. L., Allay, E., Norton, K., & Gerson, S. L. (1993) · Science · doi:10.1126/science.8421782 · Cited by 236
Self-citationPegg, A. E. (1984) · Cancer Investigation · doi:10.3109/07357908409104376 · Cited by 236
Liu, L., Markowitz, S. D., & Gerson, S. L. (1996) · PubMed · Cited by 235
Self-citationTong, W. P., KIRK, M. C., & Ludlum, D. B. (1982) · PubMed · Cited by 223
Srivenugopal, K. S., Yuan, X.-H., Friedman, H. S., & Ali-Osman, F. (1996) · Biochemistry · doi:10.1021/bi9518205 · Cited by 218
van Leeuwen, F. E., Chorus, A. M., van den Belt-Dusebout, A. W., Hagenbeek, A., Noyon, R., van Kerkhoff, E. H., Pinedo, H. M., & Somers, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1063 · Cited by 189
Liu, L., Taverna, P., Whitacre, C. M., Chatterjee, S., & Gerson, S. L. (1999) · PubMed · Cited by 162
Self-citationMechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine
Pegg, A. E., Boosalis, M. S., Samson, L. D., Moschel, R. C., Byers, T. L., Swenn, K., & Dolan, M. E. (1993) · Biochemistry · doi:10.1021/bi00096a009 · Cited by 151
Glassner, B. J. (1999) · Mutagenesis · doi:10.1093/mutage/14.3.339 · Cited by 149
Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene
Harris, L. C., Potter, P. M., Tano, K., Shiota, S., MITRA, S. P., & Brent, T. P. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6163 · Cited by 139
Silber, J. R., Blank, A., Bobola, M. S., Ghatan, S., Kolstoe, D. D., & Berger, M. S. (1999) · PubMed · Cited by 135
Zaidi, N. H., Pretlow, T. P., O’Riordan, M. A., Dumenco, L. L., Allay, E. R., & Gerson, S. L. (1995) · Carcinogenesis · doi:10.1093/carcin/16.3.451 · Cited by 133
Self-citationCrystal structure of the human O6-alkylguanine-DNA alkyltransferase
Wibley, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.393 · Cited by 130
Spiro, T. P., Gerson, S. L., Liu, L., Majka, S. M., Haaga, J. R., Hoppel, C. L., Ingalls, S. T., Pluda, J. M., & Willson, J. K. V. (1999) · PubMed · Cited by 126
Self-citationRagg, S., Xu‐Welliver, M., Bailey, J., D'Souza, M., Cooper, R. J., Chandra, S., Seshadri, R. S., Pegg, A. E., & Williams, D. A. (2000) · PubMed · Cited by 124
Sawai, N., Zhou, S., Vanin, E. F., Houghton, P. J., Brent, T. P., & Sorrentino, B. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0223 · Cited by 115
Davis, B. M., Reese, J., Koç, O. N., Lee, K., Schupp, J. E., & Gerson, S. L. (1997) · PubMed · Cited by 114
Self-citationDolan, M. E., Stine, L., Mitchell, R. B., Moschel, R. C., & Pegg, A. E. (1990) · Cancer Communications · doi:10.3727/095535490820873985 · Cited by 94
Microsatellite instability and DNA mismatch repair in human cancer
Karran, P. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0003 · Cited by 93
Dowlati, A., Haaga, J. R., Remick, S. C., Spiro, T. P., Gerson, S. L., Liu, L., Berger, S. J., Berger, N. A., & Willson, J. K. V. (2001) · PubMed · Cited by 91
Self-citationO6‐methylguanine‐DNA methyltransferase activity in breast and brain tumors
Preuss, I., Eberhagen, I., Haas, S. A., Eibl, R. H., Kaufmann, M., Minckwitz, G. V., & Kaina, B. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610308 · Cited by 88
Redmond, S. M. S., Joncourt, F., Buser, K., Ziemiecki, A., Altermatt, H. J., Fey, M. F., Margison, G. P., & Cerny, T. (1991) · PubMed · Cited by 86
Daniels, D. S., & Tainer, J. A. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00024-0 · Cited by 82
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
Dolan, M. E., Roy, S. K., Fasanmade, A. A., Paras, P. R., Schilsky, R. L., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1803 · Cited by 82
Aquilina, G., Hess, P., Branch, P., MacGeoch, C., Casciano, I., Karran, P., & Bignami, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8905 · Cited by 77
Liu, L. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.279 · Cited by 77
Koç, O. N., Reese, J., Davis, B. M., Liu, L., Majczenko, K. J., & Gerson, S. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950018418 · Cited by 60
Self-citationArmstrong, M. J., & Galloway, S. M. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(96)00234-5 · Cited by 58
Kokkinakis, D. M., Ahmed, M. M., Delgado, R., Fruitwala, M. A., Mohiuddin, M., & Albores‐Saavedra, J. (1997) · PubMed · Cited by 56
Srivenugopal, K. S., Mullapudi, S., Shou, J., et al. (2000) · PubMed · Cited by 54
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
Johnson, S. P., Loktionova, N. A., Dolan, M. E., Modrich, P. L., Struck, R. F., Brent, T. P., Ludeman, S. M., Keir, S., Dong, Q. D., Colvin, O. M., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050866 · Cited by 53
Pegg, A. E., Swenn, K., Chae, M.-Y., Dolan, M. E., & Moschel, R. C. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00249-y · Cited by 46
Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine
Gerson, S. L., Berger, N. A., Arce, C., Petzold, S. J., & Willson, J. K. V. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90618-s · Cited by 43
Self-citationZaidi, N. H., Liu, L., & Gerson, S. L. (1996) · PubMed · Cited by 43
Self-citationKreklau, E. L., Kurpad, C., Williams, D. A., & Erickson, L. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35236-x · Cited by 40
Chen, Z. P., Yarosh, D. B., Garcia, Y., Tampieri, D. I., Mohr, G., Malapetsa, A., Langleben, A., & Panasci, L. (1999) · PubMed · Cited by 38
Loktionova, N. A., & Pegg, A. E. (1996) · PubMed · Cited by 37
Smith, D. C., Gerson, S. L., Liu, L., Donnelly, S., Day, R., Trump, D. L., & Kirkwood, J. M. (1996) · PubMed · Cited by 33
Self-citationMinnick, D. T., Gerson, S. L., Dumenco, L. L., et al. (1993) · PubMed · Cited by 32
Self-citationLiu, L., Lee, K. H., Wasan, E. K., & Gerson, S. L. (1996) · PubMed · Cited by 18
Self-citationExpression of DNA Mismatch Repair Proteins in Acute Lymphoblastic Leukaemia and Normal Bone Marrow
Matheson, E. C., & Hall, A. G. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_64 · Cited by 16
Rossi, S. C., & Topal, M. D. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.3.1201-1207.1991 · Cited by 10
Carcinogenesis by nitrosamines and azoxyalkanes by different routes of administration to rats.
Lijinsky, W., & Kovatch, R. M. (1989) · PubMed · Cited by 9
Cited by
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Hegi, M. E., Liu, L., Herman, J. G., Stupp, R., Wick, W., Weller, M., Mehta, M. P., & Gilbert, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5964 · Cited by 812
Alkylation damage in DNA and RNA—repair mechanisms and medical significance
Drabløs, F., Feyzi, E., Aas, P. A., Vaagbø, C. B., Kavli, B., Bratlie, M. S., Peña-Diaz, J., Otterlei, M., Slupphaug, G., & Krokan, H. E. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.05.004 · Cited by 648
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
Stupp, R., Hegi, M. E., Gilbert, M. R., & Chakravarti, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8554 · Cited by 529
Ostermann, S., Csajka, C., Buclin, T., Leyvraz, S., Lejeune, F., Decosterd, L. A., & Stupp, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0807 · Cited by 518
Metadata
- Authors
- Gerson, S. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-05-01
- Volume
- 20
- Issue
- 9
- Pages
- 2388-2399
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1988299559
- Cited by
- 428
- References
- 53
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.